# NRIX (Nurix Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Nurix Therapeutics, Inc. reported $701.9M in revenue and net income of $294.9M for the trailing twelve months ended August 31, 2026 (up 8426.3% year over year), with a 41.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/NRIX
- Markdown: https://convexityos.com/fundamentals/NRIX.md
- SEC CIK: 0001549595
- Reporting currency: USD
- Latest filing period: August 31, 2026
- Last synced: Nov 20, 2026, 05:24 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001549595&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $701.9M | +8426.3% YoY |
| Operating Income | TTM | $289.7M | 41.3% margin |
| Net Income | TTM | $294.9M | 42.0% net margin |
| Diluted EPS | TTM | $2.54 | Split-adjusted |
| Free Cash Flow | TTM | $369.8M | 52.7% FCF margin |
| Cash & ST Investments | Aug 31, 2026 | $720.2M | Total debt: $65.33M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $83.98M | $54.55M | $76.99M | $38.63M | $29.75M | $17.82M | $31.11M |
| Research & Development | $316.9M | $221.6M | $189.1M | $184.5M | $116.4M | $66.49M | $45.02M |
| Total Operating Expenses | $369.6M | $267.6M | $232.1M | $222.5M | $147.6M | $82.80M | $53.35M |
| **Operating Income** | -$285.7M | -$213.0M | -$155.1M | -$183.9M | -$117.9M | -$64.98M | -$22.24M |
| **EBITDA** | -$276.9M | -$203.7M | -$147.5M | -$178.5M | -$115.1M | -$62.80M | -$19.88M |
| Income Before Tax | -$263.7M | -$193.3M | -$143.9M | -$180.4M | -$117.1M | -$63.78M | -$21.46M |
| Income Tax Expense | $760K | $270K | $0 | $0 | $131K | -$20.54M | $239K |
| **Net Income** | -$264.5M | -$193.6M | -$143.9M | -$180.4M | -$117.2M | -$43.24M | -$21.70M |
| Basic EPS | -$3.05 | -$2.88 | -$2.65 | -$3.71 | -$2.73 | -$2.76 | -$6.59 |
| **Diluted EPS** | -$3.05 | -$2.88 | -$2.65 | -$3.71 | -$2.73 | -$2.76 | -$6.59 |
| Basic Shares Outstanding | 86.7M | 67.1M | 54.3M | 48.6M | 42.9M | 15.7M | 3.3M |
| Diluted Shares Outstanding | 86.7M | 67.1M | 54.3M | 48.6M | 42.9M | 15.7M | 3.3M |

### Income Statement (Quarterly)

| Line Item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $673.1M | $9.04M | $6.25M | $13.58M | $7.89M | $44.06M | $18.45M | $13.28M |
| Research & Development | $79.26M | $87.65M | $84.14M | $83.02M | $86.12M | $78.10M | $69.66M | $67.22M |
| Total Operating Expenses | $113.6M | $103.2M | $98.75M | $96.67M | $99.28M | $92.38M | $81.32M | $77.94M |
| **Operating Income** | $559.5M | -$94.20M | -$92.50M | -$83.09M | -$91.39M | -$48.32M | -$62.86M | -$64.66M |
| **EBITDA** | $561.6M | -$91.95M | -$90.30M | -$80.97M | -$89.36M | -$46.08M | -$60.51M | -$62.11M |
| Income Before Tax | $563.4M | -$89.81M | -- | -$78.22M | -$86.42M | -$42.70M | -$56.35M | -$58.54M |
| Income Tax Expense | $13.61M | -$271K | $0 | $0 | $0 | $760K | $0 | $8.0K |
| **Net Income** | $549.8M | -$89.53M | -$87.17M | -$78.22M | -$86.42M | -$43.46M | -$56.35M | -$58.55M |
| Basic EPS | $4.93 | -$0.81 | -$0.79 | -- | -$1.03 | -$0.52 | -$0.67 | -- |
| **Diluted EPS** | $4.73 | -$0.81 | -$0.79 | -- | -$1.03 | -$0.52 | -$0.67 | -- |
| Basic Shares Outstanding | 111.6M | 111.1M | 110.1M | -- | 84.2M | 83.9M | 83.6M | -- |
| Diluted Shares Outstanding | 116.2M | 111.1M | 110.1M | -- | 84.2M | 83.9M | 83.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $247.0M | $110.0M | $54.63M | $64.47M | $80.51M | $119.4M | $34.82M |
| Short-Term Investments | -- | -- | -- | $244.7M | $215.2M | $161.8M | $2.90M |
| **Cash & Short-Term Investments** | $592.9M | $609.6M | $287.9M | $309.1M | $295.7M | $281.1M | $37.72M |
| Accounts Receivable, Net | $0 | $0 | -- | $0 | $6.00M | -- | -- |
| **Total Current Assets** | $606.8M | $619.4M | $295.5M | $318.4M | $311.1M | $298.4M | $39.35M |
| Property, Plant & Equipment, Net | $22.49M | $17.76M | $16.81M | $17.16M | $11.34M | $6.67M | $3.87M |
| Long-Term Investments | -- | -- | -- | $63.88M | $137.2M | $90.89M | $506K |
| Other Non-Current Assets | $7.34M | $3.16M | $3.82M | $4.02M | $2.83M | $177K | $147K |
| **Total Non-Current Assets** | $81.32M | $49.96M | $60.09M | $98.31M | $165.7M | $97.91M | $4.69M |
| **Total Assets** | $688.1M | $669.3M | $355.6M | $416.8M | $476.8M | $396.3M | $44.05M |
| Accounts Payable | $11.21M | $11.48M | $6.40M | $5.06M | $6.65M | $3.41M | $1.60M |
| Deferred Revenue (Current) | $17.58M | $38.36M | $48.10M | $37.63M | $41.21M | $32.80M | $9.61M |
| Other Current Liabilities | $2.10M | $2.27M | $751K | $1.50M | $659K | $700K | $309K |
| **Total Current Liabilities** | $86.47M | $95.85M | $86.96M | $70.66M | $66.26M | $44.54M | $16.14M |
| Deferred Revenue (Non-Current) | $10.01M | $26.21M | $45.02M | $35.97M | $59.02M | $60.69M | $35.69M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $850K | $1.74M |
| **Total Non-Current Liabilities** | $62.92M | $46.50M | $68.15M | $42.41M | $68.21M | $61.53M | $37.43M |
| **Total Liabilities** | $149.4M | $142.3M | $155.1M | $113.1M | $134.5M | $106.1M | $53.57M |
| **Total Debt (incl. Leases)** | $55.73M | $28.30M | $30.61M | $11.96M | $13.04M | -- | -- |
| Common Stock | $102K | $76K | $49K | $47K | $45K | $39K | $4.0K |
| Retained Earnings | -$1.00B | -$738.8M | -$545.2M | -$401.3M | -$220.9M | -$103.7M | -$60.46M |
| Accumulated Other Comp. Income | $105K | $150K | -$655K | -$4.32M | -$608K | $87K | -$2.0K |
| **Total Stockholders' Equity** | $538.7M | $527.0M | $200.5M | $303.7M | $342.3M | $290.3M | -$57.71M |
| Total Equity | $538.7M | $527.0M | $200.5M | $303.7M | $342.3M | $290.3M | -$57.71M |

### Balance Sheet (Quarterly)

| Line Item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $720.2M | $67.69M | $71.19M | $247.0M | $78.44M | $84.26M | $75.92M | $110.0M |
| **Cash & Short-Term Investments** | $1.10B | $443.5M | $540.7M | $592.9M | $428.8M | $485.8M | $549.7M | $609.6M |
| Accounts Receivable, Net | $20.00M | -- | -- | $0 | -- | $19.00M | -- | $0 |
| **Total Current Assets** | $1.10B | $456.5M | $554.4M | $606.8M | $440.6M | $515.3M | $563.7M | $619.4M |
| Property, Plant & Equipment, Net | $19.41M | $20.01M | $21.70M | $22.49M | $20.50M | $18.77M | $18.45M | $17.76M |
| Other Non-Current Assets | $7.95M | $7.98M | $7.41M | $7.34M | $7.38M | $6.34M | $5.63M | $3.16M |
| **Total Non-Current Assets** | $91.61M | $79.06M | $81.74M | $81.32M | $81.87M | $76.22M | $51.34M | $49.96M |
| **Total Assets** | $1.20B | $535.5M | $636.1M | $688.1M | $522.5M | $591.6M | $615.0M | $669.3M |
| Accounts Payable | $32.98M | $12.21M | $10.29M | $11.21M | $8.61M | $5.95M | $8.40M | $11.48M |
| Deferred Revenue (Current) | $8.61M | $13.32M | $18.75M | $17.58M | $25.99M | $27.42M | $30.59M | $38.36M |
| Other Current Liabilities | $1.49M | $1.30M | $1.93M | $2.10M | $1.73M | $1.04M | $2.69M | $2.27M |
| **Total Current Liabilities** | $130.7M | $72.02M | $92.20M | $86.47M | $82.35M | $75.61M | $89.99M | $95.85M |
| Deferred Revenue (Non-Current) | $10.78M | $5.97M | $7.58M | $10.01M | $15.18M | $21.64M | $24.15M | $26.21M |
| **Total Non-Current Liabilities** | $96.25M | $60.89M | $63.04M | $62.92M | $67.87M | $68.34M | $44.14M | $46.50M |
| **Total Liabilities** | $227.0M | $132.9M | $155.2M | $149.4M | $150.2M | $144.0M | $134.1M | $142.3M |
| **Total Debt (incl. Leases)** | $65.33M | $58.14M | $58.66M | $55.73M | $56.49M | $51.93M | $26.62M | $28.30M |
| Common Stock | $109K | $104K | $103K | $102K | $77K | $76K | $76K | $76K |
| Retained Earnings | -$630.1M | -$1.18B | -$1.09B | -$1.00B | -$925.0M | -$838.6M | -$795.1M | -$738.8M |
| Accumulated Other Comp. Income | -$210K | -$145K | $56K | $105K | $119K | -$20K | $226K | $150K |
| **Total Stockholders' Equity** | $968.3M | $402.6M | $480.9M | $538.7M | $372.3M | $447.6M | $480.9M | $527.0M |
| Total Equity | $968.3M | $402.6M | $480.9M | $538.7M | $372.3M | $447.6M | $480.9M | $527.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$264.5M | -$193.6M | -$143.9M | -$180.4M | -$117.2M | -$43.24M | -$21.70M |
| Depreciation & Amortization | $8.74M | $9.32M | $7.53M | $5.35M | $2.79M | $2.18M | $2.35M |
| Stock-Based Compensation | $37.97M | $33.93M | $33.67M | $28.13M | $15.80M | $4.30M | $510K |
| Change in Receivables | -- | $0 | $0 | $6.00M | -$6.00M | -- | -- |
| Change in Payables | -$630K | $5.21M | $1.61M | $85K | $1.59M | $1.23M | $302K |
| **Operating Cash Flow** | -$249.5M | -$172.6M | -$81.36M | -$159.8M | -$84.36M | -$80K | $601K |
| Capital Expenditure | -$14.00M | -$9.27M | -$8.40M | -$12.24M | -$5.66M | -$4.55M | -$1.65M |
| **Free Cash Flow** | -$263.5M | -$181.9M | -$89.77M | -$172.1M | -$90.03M | -$4.63M | -$1.05M |
| Purchases of Investments | -$455.7M | -$708.0M | -$246.3M | -$239.4M | -$348.5M | -$275.2M | -$9.35M |
| Sales & Maturities of Investments | $617.5M | $459.5M | $323.0M | $278.8M | $238.9M | $25.37M | $19.50M |
| **Investing Cash Flow** | $147.9M | -$257.7M | $68.30M | $27.20M | -$108.3M | -$254.4M | $8.50M |
| Common Stock Issued | $0 | $289.8M | $0 | $19.40M | $150.2M | $218.1M | -- |
| **Financing Cash Flow** | $238.6M | $485.7M | $3.22M | $117.2M | $153.9M | $339.0M | $126K |
| **Net Change in Cash** | $137.0M | $55.37M | -$9.85M | -$15.42M | -$38.73M | $84.54M | $9.22M |

### Cash Flow Statement (Quarterly)

| Line Item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $549.8M | -$89.53M | -$87.17M | -$78.22M | -$86.42M | -$43.46M | -$56.35M | -$58.55M |
| Depreciation & Amortization | $2.14M | $2.25M | $2.20M | $2.12M | $2.03M | $2.24M | $2.35M | $2.55M |
| Stock-Based Compensation | $10.78M | $11.39M | $9.40M | $9.09M | $9.77M | $10.38M | $8.72M | $8.51M |
| Change in Payables | $20.61M | $1.87M | -$461K | $3.02M | $2.23M | -$2.68M | -$3.21M | $7.58M |
| **Operating Cash Flow** | $615.6M | -$96.57M | -$71.91M | -$67.83M | -$57.38M | -$63.16M | -$61.09M | -$48.75M |
| Capital Expenditure | -$1.39M | -$1.94M | -$1.04M | -$5.13M | -$2.71M | -$2.67M | -$3.48M | -$2.10M |
| **Free Cash Flow** | $614.2M | -$98.51M | -$72.96M | -$72.96M | -$60.10M | -$65.84M | -$64.57M | -$50.86M |
| Purchases of Investments | -$149.4M | -$24.63M | -$255.9M | -$174.3M | -$103.0M | -$68.17M | -$110.2M | -$298.2M |
| Sales & Maturities of Investments | $182.4M | $119.6M | $133.2M | $179.8M | $156.2M | $142.3M | $139.2M | $159.5M |
| **Investing Cash Flow** | $31.58M | $93.00M | -$123.8M | $346K | $50.48M | $71.50M | $25.53M | -$140.8M |
| Common Stock Issued | $0 | $0 | $18.00M | $0 | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $5.16M | $66K | $19.98M | $236.0M | $1.16M | $6.0K | $1.47M | $200.5M |
| **Net Change in Cash** | $652.4M | -$3.51M | -$175.8M | $168.5M | -$5.75M | $8.34M | -$34.08M | $10.95M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -340.2% | -390.5% | -201.4% | -476.0% | -396.3% | -364.7% | -71.5% |
| **Net Profit Margin** | -314.9% | -354.9% | -187.0% | -466.9% | -393.9% | -242.7% | -69.7% |
| Return on Equity (ROE) | -49.1% | -36.7% | -71.8% | -59.4% | -34.2% | -14.9% | -- |
| Return on Assets (ROA) | -38.4% | -28.9% | -40.5% | -43.3% | -24.6% | -10.9% | -49.3% |
| Current Ratio | 7.02x | 6.46x | 3.40x | 4.51x | 4.70x | 6.70x | 2.44x |
| Quick Ratio | 6.86x | 6.36x | 3.31x | 4.37x | 4.55x | 6.31x | 2.34x |
| Debt to Equity | 0.10x | 0.05x | 0.15x | 0.04x | 0.04x | -- | -- |
| **Revenue Growth (YoY)** | +54.0% | -29.1% | +99.3% | +29.8% | +66.9% | -42.7% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -113.3% | -- |
| 5Y Revenue / Share Growth | -14.8% | -91.4% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 41.3% | -982.4% | -439.3% | -340.2% | -319.3% | -260.8% | -408.9% | -390.5% |
| **Net Profit Margin** | 42.0% | -928.4% | -411.4% | -314.9% | -292.5% | -234.6% | -369.4% | -354.9% |
| Return on Equity (ROE) | 30.5% | -84.8% | -61.4% | -49.1% | -65.8% | -46.3% | -43.3% | -36.7% |
| Return on Assets (ROA) | 24.7% | -63.7% | -46.4% | -38.4% | -46.9% | -35.0% | -33.9% | -28.9% |
| Current Ratio | 8.44x | 6.34x | 6.01x | 7.02x | 5.35x | 6.82x | 6.26x | 6.46x |
| Quick Ratio | 8.57x | 6.16x | 5.86x | 6.86x | 5.21x | 6.68x | 6.11x | 6.36x |
| Debt to Equity | 0.07x | 0.14x | 0.12x | 0.10x | 0.15x | 0.12x | 0.06x | 0.05x |
| **Revenue Growth (YoY)** | +8426.3% | -79.5% | -66.1% | +2.2% | -37.3% | +264.3% | +11.3% | -12.4% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -282.7% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -311.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
